Contract Research & Services
Contract Research

Hepatic Impairment Studies in Early Development Services: Innovative Patient Pharmacology Models for Phase I-IIa Support

Published 19 September 2014 | By PRA Health Sciences

PRA Early Development Services (EDS) has established a group of experts dedicated to early phase patient studies. Our innovative Patient Pharmacology Services (PPS) features a unique scientific/medical and operational model that enables us to conduct studies in patients with hepatic impairment following the same processes and guidelines that we apply to traditional Phase I or Phase IIa trials.

Available Downloads

Hepatic Impairment Studies in Early Development Services: Innovative Patient Pharmacology Models for Phase I-IIa Support